Citigroup Inc. Boosts Position in Align Technology, Inc. $ALGN

Citigroup Inc. raised its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN) by 28.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 313,807 shares of the medical equipment provider’s stock after acquiring an additional 68,597 shares during the period. Citigroup Inc. owned approximately 0.44% of Align Technology worth $39,295,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in ALGN. Rothschild Investment LLC raised its holdings in shares of Align Technology by 140.3% during the second quarter. Rothschild Investment LLC now owns 149 shares of the medical equipment provider’s stock worth $28,000 after purchasing an additional 87 shares during the last quarter. True Wealth Design LLC raised its stake in shares of Align Technology by 7,650.0% during the 2nd quarter. True Wealth Design LLC now owns 155 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 153 shares during the last quarter. Sentry Investment Management LLC raised its stake in shares of Align Technology by 73.1% during the 3rd quarter. Sentry Investment Management LLC now owns 187 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 79 shares during the last quarter. CYBER HORNET ETFs LLC acquired a new position in shares of Align Technology in the 2nd quarter valued at about $36,000. Finally, MUFG Securities EMEA plc purchased a new stake in shares of Align Technology in the second quarter worth about $38,000. 88.43% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Align Technology news, EVP John Morici sold 7,969 shares of the stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $189.31, for a total transaction of $1,508,611.39. Following the completion of the transaction, the executive vice president owned 8,237 shares of the company’s stock, valued at $1,559,346.47. This represents a 49.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.66% of the company’s stock.

Align Technology Stock Performance

Align Technology stock opened at $185.53 on Wednesday. The stock has a market capitalization of $13.31 billion, a P/E ratio of 32.78, a P/E/G ratio of 1.99 and a beta of 1.84. The company’s fifty day moving average price is $170.56 and its 200 day moving average price is $150.07. Align Technology, Inc. has a 1 year low of $122.00 and a 1 year high of $208.30.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings data on Wednesday, February 4th. The medical equipment provider reported $3.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.99 by $0.30. The business had revenue of $1.05 billion for the quarter, compared to the consensus estimate of $1.03 billion. Align Technology had a net margin of 10.17% and a return on equity of 15.16%. The company’s revenue was up 5.3% compared to the same quarter last year. During the same period last year, the firm posted $2.44 earnings per share. Sell-side analysts predict that Align Technology, Inc. will post 7.98 EPS for the current year.

Align Technology News Summary

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Zacks published a “strong value” read on ALGN, highlighting favorable Style Scores that may attract value-oriented investors and lift demand. Read More.
• Positive Sentiment: Zacks also featured ALGN as a top momentum stock and noted it is outpacing many medical peers this year — commentary that can support momentum-driven buying and analyst optimism. Read More. · Read More.
• Positive Sentiment: Product/market expansion: Align rolled out the iTero Lumina intraoral scanner in Saudi Arabia at a major dental conference — a commercial expansion that supports international growth and device revenue potential. Read More.
• Positive Sentiment: Market commentary: Barchart summarized Wall Street’s generally favorable stance on Align, citing improving momentum and steady execution — an analyst tone that tends to support multiple expansion. Read More.
• Neutral Sentiment: Short-interest report appears to contain erroneous/empty data (shows 0 shares / NaN change and 0 days to cover); it offers no actionable signal to the market in its current form.
• Negative Sentiment: Insider activity: An Align EVP sold about $1.5M of stock — a disclosure that can create short-term selling pressure or caution among some investors. Read More.
• Negative Sentiment: Short-term performance note: MarketWatch flagged that ALGN recently underperformed peers on a particular trading day, which may weigh on sentiment for short-term traders. Read More.

Analysts Set New Price Targets

Several brokerages recently weighed in on ALGN. Stifel Nicolaus lifted their price target on Align Technology from $200.00 to $210.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. HSBC raised their price objective on shares of Align Technology from $140.00 to $150.00 in a research note on Friday, October 31st. Robert W. Baird set a $218.00 target price on shares of Align Technology in a report on Thursday, February 5th. Weiss Ratings raised shares of Align Technology from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, January 16th. Finally, Needham & Company LLC restated a “hold” rating on shares of Align Technology in a research report on Thursday, October 30th. Six equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $195.58.

Align Technology Company Profile

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.